Eikon Therapeutics, Inc. Common Stock EIKN
$10.83
-1.19%
at last close
Market Cap$593.65 million
P/E Ratio—
Div Yield—
Volume72.2K
52-Week Range
$7.90$17.40
Analyst Ratings
- Consensus
- Moderate Buy — 5 Buy · 0 Hold · 1 Sell (6 analysts)
- Avg. Price Target
- $25.00 (+130.8% upside)
Key Stats
- Today's Range
- $10.62 – $10.98
- 50-Day Range
- $8.72 – $14.51
- 52-Week Range
- $7.90 – $17.40
- Volume
- 72K shs
- Average Volume
- 423K shs
- Market Cap
- $593.65 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 1.27
- Price / Sales
- —
Short Interest
- Short Interest
- 1.60%
- Days to Cover
- 1.18
About Eikon Therapeutics, Inc. Common Stock
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.
Related Stocks
Compare head-to-head: EIKN vs AMGN·EIKN vs MRNA·EIKN vs HALO·EIKN vs KRYS
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.